3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Prostatic Neoplasms
80
Breast Neoplasms
39
Neoplasms
6
Neoplasm Metastasis
4
Leiomyoma
2
Infertility
2
Breast Neoplasms, Male
2
Stage I Prostate Adenocarcinoma AJCC v7
1
Sexual Dysfunction, Physiological
1
Sarcopenia
1
Salivary Gland Neoplasms
1
Recurrence
1
Primary Dysautonomias
1
Patient Compliance
1
Ovarian Neoplasms
1
Osteoporosis
1
Osteitis Deformans
1
Lymphatic Metastasis
1
Kidney Diseases
1
Hypertension
1
Hyperlipidemias
1
Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer
1
Hodgkin Disease
1
Hereditary Sensory and Autonomic Neuropathies
1
Hemorrhage
1
Fallopian Tube Neoplasms
1
Castrate Sensitive Prostate Cancer
1
Carcinoma, Ovarian Epithelial
1
Bulbo-Spinal Atrophy, X-Linked
1
Advanced Prostate Cancer
1
Interventions
vistusertib
1
ribociclib
1
Tamoxifen
1
Letrozole
1
Goserelin
1
Fulvestrant
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Advanced Metastatic Breast Cancer
×
Goserelin
×
Clear all
NCT02278120
2024-03-12
MONALEESA-7
Novartis
Phase 3
Completed
672 enrolled
16 charts
1 FDA